MedPath

Evaluation of Sinetrol® Xpur in Fat Mass Reduction on Overweight and Obese Subjects

Not Applicable
Completed
Conditions
Change in Total Body Fat Mass Percentage Loss Versus Body Weight
Registration Number
NCT04149158
Lead Sponsor
Fytexia
Brief Summary

This study aims to evaluate effects of a 16-week supplementation with a polyphenol rich extract, Sinetrol® Xpur, on fat mass accumulation and body weight management improvement.Subjects were overweight or obese and received polyphenol supplement or placebo. A 4-week follow-up as performed to evaluate its effect after supplementation stop.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
77
Inclusion Criteria
  • overweight or obese (25 kg.m-2<BMI<42.5kg.m-2)
  • healthy
Exclusion Criteria
  • metabolic or chronical disease with treatments (i.e.: diabetes, dyslipidemia, thyroiditis, inflammatory disease, immunological disease, infectious disease, asthma, anxiety and depression)
  • food allergy to the ingredients of the product (grapefruit, orange, caffeine, guarana)
  • involved in the prior 6 months in a chronic treatment program, eating disorders history, subjected to weight reduction by surgery
  • start or quit smoking, high alcohol consumption
  • pregnant, breastfeeding, wanting to have a baby,
  • menopausal women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in total body fat percentage loss versus bodyweightweek1; week16; week20
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UCAM

🇪🇸

Murcia, Spain

UCAM
🇪🇸Murcia, Spain

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.